том 40 издание 19 страницы 2119-2127

Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity

Тип публикацииJournal Article
Дата публикации2022-07-01
scimago Q1
wos Q1
БС1
SJR11.205
CiteScore38.9
Impact factor41.9
ISSN0732183X, 15277755
Cancer Research
Oncology
Краткое описание
PURPOSE

Gorlin syndrome (GS) is a rare genetic disorder characterized by lifetime risk of basal cell carcinomas (BCCs), skeletal anomalies (SAs), and other extracutaneous neoplasms. There is great variation in disease severity, and a genotype-phenotype correlation has not been well established. Here, we investigate whether patients' clinical characteristics predict disease severity to inform clinical decision making.

METHODS

Data of 248 patients with GS were collected between 2014 and 2021 from three institutions. Multivariable regression analyses were performed to investigate whether clinical characteristics predicted disease burden. Genotype-phenotype correlations were investigated in 40 patients.

RESULTS

Patients with SAs had a mean increase of 120 lifetime BCCs (95% CI, 27.1 to 213) relative to patients without SAs. Those with ≥ 2 SAs had 2.45 increased odds (95% CI, 1.01 to 5.91) of advanced or metastatic BCCs. Moreover, the presence of multiple SAs was associated with 5.00 increased odds of having a keratocystic odontogenic tumor (95% CI, 2.22 to 11.3) and 2.79 increased odds of an ovarian fibroma (95% CI, 1.05 to 7.40). Genotype-phenotype analyses showed that missense/in-frame mutations were more likely to be hereditary compared with severe deleterious mutation types (100% v 27%; P = .004). In addition, heat map visualization illustrated that those with more deleterious variants, like large deletions, trended toward increased burden of SAs and BCCs per year.

CONCLUSION

GS patients with SAs may be at greater risk for developing more numerous and severe BCCs and other neoplastic growths including keratocystic odontogenic tumors and ovarian fibromas. Current clinical guidelines suggest yearly follow-up in individuals with GS. Since SAs are usually recognized at the time of diagnosis, our results suggest that more vigilant lifetime multidisciplinary surveillance should be considered for these patients starting in childhood.

Найдено 
Найдено 

Топ-30

Журналы

1
Pediatric and Developmental Pathology
1 публикация, 11.11%
Journal of Cutaneous Medicine and Surgery
1 публикация, 11.11%
Oral
1 публикация, 11.11%
European Journal of Cancer
1 публикация, 11.11%
Annales de Dermatologie et de Vénéréologie - FMC
1 публикация, 11.11%
Cancers
1 публикация, 11.11%
EClinicalMedicine
1 публикация, 11.11%
Australasian Journal of Dermatology
1 публикация, 11.11%
Cureus
1 публикация, 11.11%
1

Издатели

1
2
3
Elsevier
3 публикации, 33.33%
SAGE
2 публикации, 22.22%
MDPI
2 публикации, 22.22%
Wiley
1 публикация, 11.11%
Springer Nature
1 публикация, 11.11%
1
2
3
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
9
Поделиться
Цитировать
ГОСТ |
Цитировать
Betancourt N. et al. Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity // Journal of Clinical Oncology. 2022. Vol. 40. No. 19. pp. 2119-2127.
ГОСТ со всеми авторами (до 50) Скопировать
Betancourt N., Friedlander M. S., Pickford J. R., Bailey I., Tang J. Y., Teng J. Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity // Journal of Clinical Oncology. 2022. Vol. 40. No. 19. pp. 2119-2127.
RIS |
Цитировать
TY - JOUR
DO - 10.1200/jco.21.02385
UR - https://doi.org/10.1200/jco.21.02385
TI - Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity
T2 - Journal of Clinical Oncology
AU - Betancourt, Nicolas
AU - Friedlander, Mollie S.H.
AU - Pickford, Jean R
AU - Bailey, Irene
AU - Tang, Jean Y.
AU - Teng, Joyce
PY - 2022
DA - 2022/07/01
PB - American Society of Clinical Oncology (ASCO)
SP - 2119-2127
IS - 19
VL - 40
PMID - 35333541
SN - 0732-183X
SN - 1527-7755
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2022_Betancourt,
author = {Nicolas Betancourt and Mollie S.H. Friedlander and Jean R Pickford and Irene Bailey and Jean Y. Tang and Joyce Teng},
title = {Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity},
journal = {Journal of Clinical Oncology},
year = {2022},
volume = {40},
publisher = {American Society of Clinical Oncology (ASCO)},
month = {jul},
url = {https://doi.org/10.1200/jco.21.02385},
number = {19},
pages = {2119--2127},
doi = {10.1200/jco.21.02385}
}
MLA
Цитировать
Betancourt, Nicolas, et al. “Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease Severity.” Journal of Clinical Oncology, vol. 40, no. 19, Jul. 2022, pp. 2119-2127. https://doi.org/10.1200/jco.21.02385.